inclusion criteria: 1. ≥ 18 years old 2. ability to understand and the willingness to sign a written informed consent document before any study procedure 3. metabolic syndrome or type 2 diabetes 4. coronavirus infection, severe acute respiratory syndrome sars-cov- 2 confirmed by the polymerase chain reaction test (pcr) ≤ 4 days before of the randomization. 5. hospitalized patient. 6. radiographic evidence of pulmonary infiltrates

inclusion criteria: 1. ≥ 18 years old 2. ability to understand and the willingness to sign a written informed consent document before any study procedure 3. metabolic syndrome or type 2 diabetes 4. coronavirus infection, severe acute respiratory syndrome sars-cov- 2 confirmed by the polymerase chain reaction test (pcr) ≤ 4 days before of the randomization. 5. hospitalized patient. 6. radiographic evidence of pulmonary infiltrates

inclusion criteria: ≥ 18 years old ability to understand and the willingness to sign a written informed consent document before any study procedure metabolic syndrome or type 2 diabetes coronavirus infection, severe acute respiratory syndrome sars-cov- 2 confirmed by the polymerase chain reaction test (pcr) ≤ 4 days before of the randomization. hospitalized patient. radiographic evidence of pulmonary infiltrates

inclusion criteria: ≥ 18 years old ability to understand and the willingness to sign a written informed consent document before any study procedure metabolic syndrome or type 2 diabetes coronavirus infection, severe acute respiratory syndrome sars-cov- 2 confirmed by the polymerase chain reaction test (pcr) ≤ 4 days before of the randomization. hospitalized patient. radiographic evidence of pulmonary infiltrates

inclusion criteria: 1. ≥ 18 years old 2. ability to understand and the willingness to sign a written informed consent document before any study procedure 3. metabolic syndrome or type 2 diabetes 4. coronavirus infection, severe acute respiratory syndrome sars-cov- 2 confirmed by the polymerase chain reaction test (pcr) ≤ 4 days before of the randomization. 5. hospitalized patient. 6. radiographic evidence of pulmonary infiltrates

inclusion criteria: 1. ≥ 18 years old 2. ability to understand and the willingness to sign a written informed consent document before any study procedure 3. metabolic syndrome or type 2 diabetes 4. coronavirus infection, severe acute respiratory syndrome sars-cov- 2 confirmed by the polymerase chain reaction test (pcr) ≤ 4 days before of the randomization. 5. hospitalized patient. 6. radiographic evidence of pulmonary infiltrates